Kawasaki Disease - 25 Studies Found
Withdrawn |
: Cardiovascular Risk Markers and Response to Statins After Kawasaki Disease : Kawasaki Disease : 2006-03-20 : Drug: pravastatin |
Withdrawn |
: Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease : Kawasaki Disease : 2016-10-24 : Drug: Canakinumab Other Name: ACZ885 |
Recruiting |
: Etiology Study of Kawasaki Disease : Kawasaki Disease : 2005-09-09 |
Completed |
: Infliximab (Remicade) for Patients With Acute Kawasaki Disease : Kawasaki Disease : 2005-12-30 :
|
Completed |
: Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease : Kawasaki Disease : 2012-01-25 : Drug: immunoglobulin G Intravenously administer a single dose of the product (2g/kg) for at least 12 hou |
Completed |
: A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease : Kawasaki Disease : 2005-09-09 : Drug: Sestamibi Sestamibi Other Name: Cardiolite |
Active, not recruiting |
: Etanercept in Kawasaki Disease :
|
Recruiting |
: KIDCARE (Kawasaki Disease Comparative Effectiveness Trial) : Mucocutaneous Lymph Node Syndrome : 2017-01-17 :
|
Completed |
: Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease : Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin : 2012-05-09 :
|
Recruiting |
: Anakinra and Kawasaki Disease :
: 2015-03-11 : Drug: Anakinra The dose of Anakinra will be 2mg/kg. If the patient remains febrile (fever >38°C) |